NCT01852682View on ClinicalTrials.gov

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

March 31, 2014

Conditions
Peritoneal DialysisHyperphosphatemia
Interventions
DRUG

PA21

Trial Locations (1)

Unknown

Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY